Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("WILLEMZE, Roel")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 57

  • Page / 3
Export

Selection :

  • and

An animal model for human cellular immunotherapy: specific eradication of human acute lymphoblastic leukemia by cytotoxic T lymphocytes in NOD/scid miceNIJMEIJER, Bart A; WILLEMZE, Roel; FALKENBURG, J. H et al.Blood. 2002, Vol 100, Num 2, pp 654-660, issn 0006-4971Article

Adult acute lymphoblastic leukaemiaBASSAN, Renato; GATTA, Gemma; TONDINI, Carlo et al.Critical reviews in oncology/hematology. 2004, Vol 50, Num 3, pp 223-261, issn 1040-8428, 39 p.Article

Post-remission treatment for adult patients with acute lymphoblastic leukemia in first remission : Is there a role for autologous stem cell transplantation?WILLEMZE, Roel; LABAR, Boris.Seminars in hematology. 2007, Vol 44, Num 4, pp 267-273, issn 0037-1963, 7 p.Article

Engraftment potential into NOD/SCID mice of CD34+ cells derived from human fetal liver as compared to fetal bone marrowWILPSHAAR, Jannine; NOORT, Willy A; KANHAI, Humphrey H. H et al.Haematologica (Roma). 2001, Vol 86, Num 10, pp 1021-1028, issn 0390-6078Article

Deoxycytidine kinase expression and activity in patients with resistant versus sensitive acute myeloid leukemiaVEUGER, Marjan J. T; HONDERS, M. Willy; WILLEMZE, Roel et al.European journal of haematology. 2002, Vol 69, Num 3, pp 171-178, issn 0902-4441, 8 p.Article

Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia GroupLABAR, Boris; SUCIU, Stefan; SINNIGE, Harm et al.Haematologica (Roma). 2010, Vol 95, Num 9, pp 1489-1495, issn 0390-6078, 7 p.Article

Early detection and rapid isolation of leukemia-reactive donor t cells for adoptive transfer using the IFN-γ secretion assayJEDEMA, Inge; MEIJ, Pauline; STEENEVELD, Esther et al.Clinical cancer research. 2007, Vol 13, Num 2, pp 636-643, issn 1078-0432, 8 p., 1Article

New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell populationJEDEMA, Inge; VAN DER WERFF, Nicole M; BARGE, Renée M. Y et al.Blood. 2004, Vol 103, Num 7, pp 2677-2682, issn 0006-4971, 6 p.Article

Long-term follow-up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic stem cell exhaustionDE PAUW, Elmar S. D; OTTO, Sigrid A; WIJNEN, Juul T et al.British journal of haematology. 2002, Vol 116, Num 2, pp 491-496, issn 0007-1048Article

Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT)FOUILLARD, Loïc; LABOPIN, Myriam; SICA, Simona et al.Blood. 2002, Vol 100, Num 9, pp 3135-3140, issn 0006-4971, 6 p.Article

Kinetic Preservation of Dual Specificity of Coprogrammed Minor Histocompatibility Antigen-Reactive Virus-Specific T CellsVAN LOENEN, Marleen M; HAGEDOORN, Renate S; KESTER, Michel G. D et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 5, pp 2034-2041, issn 0008-5472, 8 p.Article

Genetic engineering of virus-specific T cells with T-cell receptors recognizing minor histocompatibility antigens for clinical applicationGRIFFIOEN, Marieke; ESTHER VAN EGMOND, H. M; BARNBY-PORRITT, Helen et al.Haematologica (Roma). 2008, Vol 93, Num 10, pp 1535-1543, issn 0390-6078, 9 p.Article

Homeostasis of telomere length rather than telomere shortening after allogeneic peripheral blood stem cell transplantationROELOFS, Helene; DE PAUW, Elmar S. D; ZWINDERMAN, Aeilko H et al.Blood. 2003, Vol 101, Num 1, pp 358-362, issn 0006-4971, 5 p.Article

Inactivation of deoxycytidine kinase and overexpression of P-glycoprotein in AraC and daunorubicin double resistant leukemic cell linesVEUGER, Marjan J. T; HONDERS, M. Willy; SPOELDER, Hananja E et al.Leukemia research. 2003, Vol 27, Num 5, pp 445-453, issn 0145-2126, 9 p.Article

Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMA AML-10 trialSUCIU, Stefan; MANDELLI, Franco; LISO, Vincenzo et al.Blood. 2003, Vol 102, Num 4, pp 1232-1240, issn 0006-4971, 9 p.Article

Magnetic resonance imaging of fetal bone marrow for quantitative definition of the human fetal stem cell compartmentWILPSHAAR, Jannine; JOEKES, Elizabeth C; LIM, Frans T. H et al.Blood. 2002, Vol 100, Num 2, pp 451-457, issn 0006-4971Article

Successful outcome with a quintuple approach of posttransplant lymphoproliferative disorderSCHAAR, Cees G; VAN DER PIJL, Johan W; KLUIN-NELEMANS, Hanneke C et al.Transplantation. 2001, Vol 71, Num 1, pp 47-52, issn 0041-1337Article

Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)AMADORI, Sergio; SUCIU, Stefan; THOMAS, Xavier et al.Journal of clinical oncology. 2013, Vol 31, Num 35, pp 4424-4430, issn 0732-183X, 7 p.Article

EORTC Leukemia Group achievementsWILLEMZE, Roel; SUCIU, Stefan; WIJERMANS, Pierre et al.European journal of cancer. Supplement (1990). 2012, Vol 10, Num 1, pp 94-98, issn 1359-6349, 5 p.Article

Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup TrialDE WITTE, Theo; HAGEMEIJER, Anne; AMADORI, Sergio et al.Haematologica (Roma). 2010, Vol 95, Num 10, pp 1754-1761, issn 0390-6078, 8 p.Article

Allogeneic Stem-Cell Transplantation in Patients With Waldenström Macroglobulinemia: Report From the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationKYRIAKOU, Charalampia; CANALS, Carmen; SCHATTENBERG, Anton et al.Journal of clinical oncology. 2010, Vol 28, Num 33, pp 4926-4934, issn 0732-183X, 9 p.Article

Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancerSLAGER, Elisabeth H; HONDERS, M. Willy; FREDERIK FALKENBURG, J. H et al.Blood. 2006, Vol 107, Num 12, pp 4954-4960, issn 0006-4971, 7 p.Article

Outcomes after myeloablative unrelated donor stem cell transplantation using both in vitro and in vivo T-cell depletion with alemtuzumabVON DEM BORNE, Peter A; BEAUMONT, Floor; STARRENBURG, C. W. J Ingrid et al.Haematologica (Roma). 2006, Vol 91, Num 11, pp 1559-1562, issn 0390-6078, 4 p.Article

Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemiaCHESON, Bruce D; BENNETT, John M; LOCOCCO, Francesco et al.Journal of clinical oncology. 2003, Vol 21, Num 24, pp 4642-4649, issn 0732-183X, 8 p.Article

UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection : characterization of the critical polymorphic amino acid residues for T-cell recognitionVOGT, Mario H. J; GOULMY, Els; KLOOSTERBOER, Freke M et al.Blood. 2000, Vol 96, Num 9, pp 3126-3132, issn 0006-4971Article

  • Page / 3